Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma

키워드

참고문헌 (64)

1. Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185countries", CA Cancer J Clin, 71, pp.209~249 (2021)
2. Dawson LA, "Analysis of radiation-induced liver disease using the Lyman NTCP model", Int J Radiat Oncol Biol Phys, 53, pp.810~821 (2002)
3. Lawrence TS, "Hepatic toxicity resulting from cancer treatment", Int J Radiat Oncol Biol Phys, 31, pp.1237~1248 (1995)
4. European Association for the Study of the Liver, "EASL clinical practice guidelines : Management of hepatocellular carcinoma", J Hepatol, 69, pp.182~236 (2018)
5. Liang SX, "Dosimetric predictor identification for radiation-induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child-Pugh Grade A cirrhosis", Radiother Oncol, 98, pp.265~269 (2011)
6. Dawson LA, "Partial volume tolerance of the liver to radiation", Semin Radiat Oncol, 15, pp.279~283 (2005)
7. Kim TH, "Dosevolumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy", Int J Radiat Oncol Biol Phys, 67, pp.225~231 (2007)
8. Engelsman M, "Physics controversies in proton therapy", Semin Radiat Oncol, 23, pp.88~96 (2013)
9. Toramatsu C, "What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy", Radiat Oncol, 8, pp.48~ (2013)
10. Sun J, "Indications of IMRT, PRT and CIRT for HCC from comparisons of dosimetry and normal tissue complication possibility", Strahlenther Onkol, 198, pp.361~369 (2022)
11. Li JM, "Dose distributions of proton beam therapy for hepatocellular carcinoma:a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy", Zhonghua Yi Xue Za Zhi, 89, pp.3201~3206 (2009)
12. Wang X, "Proton radiotherapy for liver tumors : dosimetric advantages over photon plans", Med Dosim, 33, pp.259~267 (2008)
13. Kim JY, "Normal liver sparing by proton beam therapy for hepatocellular carcinoma : Comparison with helical intensity modulated radiotherapy and volumetric modulated arc therapy", Acta Oncol, 54, pp.1827~1832 (2015)
14. Smith A, "The M. D. Anderson proton therapy system", Med Phys, 36, pp.4068~4083 (2009)
15. Lomax AJ, "The clinical potential of intensity modulated proton therapy", Z Med Phys, 14, pp.147~152 (2004)
16. Bhangoo RS, "Intensity modulated proton therapy for hepatocellular carcinoma : Initial clinical experience", Adv Radiat Oncol, 6, pp.100675~ (2021)
17. Dionisi F, "Clinical results of active scanning proton therapy for primary liver tumors", Tumori, 107, pp.71~79 (2021)
18. Yoo GS, "Comparison of clinical outcomes between passive scattering versus pencilbeam scanning proton beam therapy for hepatocellular carcinoma", Radiother Oncol, 146, pp.187~193 (2020)
19. Simone CB 2nd, "Proton reirradiation : Expert recommendations for reducing toxicities and offering new chances of cure in patients with challenging recurrence malignancies", Semin Radiat Oncol, 30, pp.253~261 (2020)
20. Hashimoto T, "Repeated proton beam therapy for hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 65, pp.196~202 (2006)
21. McDuff SGR, "Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis", Pract Radiat Oncol, 8, pp.414~421 (2018)
22. Oshiro Y, "Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma", Radiother Oncol, 123, pp.240~245 (2017)
23. Cheng JY, "Proton versus photon radiotherapy for primary hepatocellular carcinoma : a propensity-matched analysis", Radiat Oncol, 15, pp.159~ (2020)
24. Qi WX, "Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma : a systematic review and meta-analysis", Radiother Oncol, 114, pp.289~295 (2015)
25. Hasan S, "Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma : practice patterns, outcomes, and the effect of biologically effective dose escalation", J Gastrointest Oncol, 10, pp.999~1009 (2019)
26. Suzuki M, "Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in Chiba(HIMAC)carbon-ion beams", Int J Radiat Oncol Biol Phys, 48, pp.241~250 (2000)
27. Komatsu S, "Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma", Cancer, 117, pp.4890~4904 (2011)
28. Kato H, "Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis", Int J Radiat Oncol Biol Phys, 59, pp.1468~1476 (2004)
29. Gandhi SJ, "Clinical decision tool for optimal delivery of liver stereotactic body radiation therapy : Photons versus protons", Pract Radiat Oncol, 5, pp.209~218 (2015)
30. Arscott WT, "Stereotactic body proton therapy for liver tumors : Dosimetric advantages and their radiobiological and clinical implications", Phys Imaging Radiat Oncol, 8, pp.17~22 (2018)
31. Chuong MD, "Consensus report from the miami liver proton therapy conference", Front Oncol, 9, pp.457~ (2019)
32. Lasley FD, "Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy", Pract Radiat Oncol, 5, pp.e443~e449 (2015)
33. Hata M, "Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis", Strahlenther Onkol, 182, pp.713~720 (2006)
34. Llovet JM, "Prognosis of hepatocellular carcinoma : the BCLC staging classification", Semin Liver Dis, 19, pp.329~338 (1999)
35. Bruix J, "Major achievements in hepatocellular carcinoma", Lancet, 373, pp.614~616 (2009)
36. Kwak HW, "Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area", J Gastroenterol Hepatol, 29, pp.820~829 (2014)
37. Korean Liver Cancer Study Group and National Cancer Center, Korea, "Practice guidelines for management of hepatocellular carcinoma 2009", Korean J Hepatol, 15, pp.391~423 (2009)
38. Kawashima M, "Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma", J Clin Oncol, 23, pp.1839~1846 (2005)
39. Chiba T, "Proton beam therapy for hepatocellular carcinoma : a retrospective review of 162 patients", Clin Cancer Res, 11, pp.3799~3805 (2005)
40. Mizumoto M, "Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis", Int J Radiat Oncol Biol Phys, 71, pp.462~467 (2008)
41. Fukumitsu N, "A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 74, pp.831~836 (2009)
42. Nakayama H, "Proton beam therapy for hepatocellular carcinoma located adjacent to the alimentary tract", Int J Radiat Oncol Biol Phys, 80, pp.992~995 (2011)
43. 김태현, "Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma", Cancer Research and Treatment, 47(1), pp.34~45 (2015), 대한암학회[DOI]
44. Hong TS, "Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, Unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma", J Clin Oncol, 34, pp.460~468 (2016)
45. Chadha AS, "Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma", Radiother Oncol, 133, pp.54~61 (2019)
46. Kim TH, "Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma", Oncotarget, 9, pp.4034~4043 (2017)
47. Kim TH, "Does risk-adapted proton beam therapy have a role as a complementary or alternative therapeutic option for hepatocellular carcinoma?", Cancers(Basel), 11, pp.230~ (2019)
48. Kim TH, "Phase II study of hypofractionated proton beam therapy for hepatocellular carcinoma", Front Oncol, 10, pp.542~ (2020)
49. Kim TH, "Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma : A randomized phase III trial", J Hepatol, 74, pp.603~612 (2021)
50. Iwata H, "A Phase 2 study of image-guided proton therapy for operable or ablation-treatable primary hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 111, pp.117~126 (2021)
51. Terayama N, "Subsegmental transcatheter arterial embolization for hepatocellular carcinoma in the caudate lobe", J Vasc Interv Radiol, 9, pp.501~508 (1998)
52. Bush DA, "Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma : Results of a randomized clinical trial", Cancer (2023)[DOI]
53. Fukuda K, "Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma", Cancer Sci, 108, pp.497~503 (2017)
54. Kim TH, "Proton beam therapy for treatment-naïve hepatocellular carcinoma and prognostic significance of albumin-bilirubin(ALBI)grade", Cancers(Basel), 14, pp.4445~ (2022)
55. Korean Liver Cancer Association (KLCA), "2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma", Clinical and Molecular Hepatology, 28(4), pp.583~705 (2022), 대한간학회
56. Finn RS, "Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma", N Engl J Med, 382, pp.1894~1905 (2020)
57. Yoon SM, "Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion : A randomized clinical trial", JAMA Oncol, 4, pp.661~669 (2018)
58. Wei X, "Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus : A randomized, open-label, multicenter controlled study", J Clin Oncol, 37, pp.2141~2151 (2019)
59. Hata M, "Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus", Cancer, 104, pp.794~801 (2005)
60. Sugahara S, "Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis", Strahlenther Onkol, 185, pp.782~788 (2009)
61. Lee SU, "Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis", Strahlenther Onkol, 190, pp.806~814 (2014)
62. Kim DY, "Riskadapted simultaneous integrated boost-proton beam therapy(SIB-PBT)for advanced hepatocellular carcinoma with tumour vascular thrombosis", Radiother Oncol, 122, pp.122~129 (2017)
63. Su CW, "Proton beam radiotherapy combined with anti-PD1", PDL1immune checkpoint inhibitors for advanced hepatocellular carcinoma, 2022, pp.12, 1606~1620
64. Wu G, "Comparison of external beam radiation therapy modalities for hepatocellular carcinoma with macrovascular invasion : A meta-analysis and systematic review", Front Oncol, 12, pp.829708~ (2022)

관련 논문AI추천